Parkinson's disease (PD) is a progressive neurodegenerative disorder that primarily affects the motor system. It is characterized by bradykinesia, resting tremor, rigidity, and postural instability. This article aims to provide healthcare professionals with a comprehensive overview of PD, including its pathophysiology, diagnosis, and management.
PD is primarily associated with the degeneration of dopaminergic neurons in the substantia nigra pars compacta. This leads to a significant reduction in striatal dopamine levels, disrupting the balance between the direct and indirect pathways of the basal ganglia, and resulting in the characteristic motor symptoms of PD. The exact cause of this neuronal degeneration remains unknown, but a combination of genetic and environmental factors is believed to contribute.
PD is primarily a clinical diagnosis based on the presence of characteristic motor symptoms. Neuroimaging techniques, such as DaTscan, can be used to support the diagnosis, but are not necessary in typical cases. Early diagnosis of PD can be challenging due to the subtle and nonspecific nature of early symptoms, emphasizing the need for a high degree of clinical suspicion.
Management of PD is primarily symptomatic, with levodopa being the most effective medication for motor symptoms. However, its long-term use can lead to motor complications, such as dyskinesias and motor fluctuations. Therefore, the timing of levodopa initiation and the choice of other dopaminergic medications must be individualized. Non-pharmacological interventions, including physiotherapy and occupational therapy, also play a crucial role in managing the disease.
PD is a complex neurodegenerative disorder that requires a comprehensive and individualized approach to diagnosis and management. Understanding the pathophysiology, recognizing the early signs, and being aware of the various therapeutic options are crucial for healthcare professionals in providing optimal care to patients with PD.
1.
Tumor characteristics found to differ for melanomas in children, teens and young adults
2.
Unexplained CAR-T Death; Americans Spurn Sunscreen; Improving Diversity in Trials
3.
"A lot" of aspirin reduces the risk of ovarian cancer, regardless of genetic factors, according to the JAMA study.
4.
Approval in Endometrial Cancer Expanded; Masks at Cancer Centers; NPR Reporter Dies
5.
Is Lenalidomide Resistance in Myeloma Reversible with JAK Inhibition?
1.
Modern Oncology Unveiled with Treatment Innovations and Personalized Cancer Care
2.
Screening for Early Therapy-Related Cancer Susceptibility
3.
Unlocking the Potential of Bicalutamide 50 mg: A Revolutionary New Treatment for Prostate Cancer
4.
Skin-Sparing Mastectomy: Balancing Cancer Control with Cosmetic Results
5.
Reducing Modifiable Childhood Cancer Exposure Risks
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Dacomitinib Case Presentation: Baseline Treatment and Current Status
2.
Targeting Oncologic Drivers with Dacomitinib: Further Discussion on Lung Cancer Treatment
3.
Should We Use DARA Up Front As First-Line Therapy in MM?
4.
Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option- A New Perspective
5.
Importance of Cancer Screening and Early Detection
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation